139 related articles for article (PubMed ID: 31945259)
1. Proprotein convertase 7 (PCSK7) reduces apoA-V levels.
Ashraf Y; Duval S; Sachan V; Essalmani R; Susan-Resiga D; Roubtsova A; Hamelin J; Gerhardy S; Kirchhofer D; Tagliabracci VS; Prat A; Kiss RS; Seidah NG
FEBS J; 2020 Aug; 287(16):3565-3578. PubMed ID: 31945259
[TBL] [Abstract][Full Text] [Related]
2. PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Sachan V; Le Dévéhat M; Roubtsova A; Essalmani R; Laurendeau JF; Garçon D; Susan-Resiga D; Duval S; Mikaeeli S; Hamelin J; Evagelidis A; Chong M; Paré G; Chernetsova E; Gao ZH; Robillard I; Ruiz M; Trinh VQ; Estall JL; Faraj M; Austin RC; Sauvageau M; Prat A; Kiss RS; Seidah NG
Metabolism; 2024 Jan; 150():155736. PubMed ID: 37967646
[TBL] [Abstract][Full Text] [Related]
3. Apoprotein A-V: an important regulator of triglyceride metabolism.
Kluger M; Heeren J; Merkel M
J Inherit Metab Dis; 2008 Apr; 31(2):281-8. PubMed ID: 18415697
[TBL] [Abstract][Full Text] [Related]
4. Is there a link between proprotein convertase PC7 activity and human lipid homeostasis?
Guillemot J; Essalmani R; Hamelin J; Seidah NG
FEBS Open Bio; 2014; 4():741-5. PubMed ID: 25349778
[TBL] [Abstract][Full Text] [Related]
5. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (
Vargas-Alarcón G; Pérez-Méndez O; González-Pacheco H; Ramírez-Bello J; Posadas-Sánchez R; Escobedo G; Fragoso JM
Cells; 2021 Jun; 10(6):. PubMed ID: 34207761
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation.
Shu X; Nelbach L; Ryan RO; Forte TM
Biochim Biophys Acta; 2010 May; 1801(5):605-8. PubMed ID: 20153840
[TBL] [Abstract][Full Text] [Related]
7. Shedding of cancer susceptibility candidate 4 by the convertases PC7/furin unravels a novel secretory protein implicated in cancer progression.
Duval S; Abu-Thuraia A; Elkholi IE; Chen R; Seebun D; Mayne J; Côté JF; Figeys D; Seidah NG
Cell Death Dis; 2020 Aug; 11(8):665. PubMed ID: 32820145
[TBL] [Abstract][Full Text] [Related]
8.
Dongiovanni P; Meroni M; Baselli G; Mancina RM; Ruscica M; Longo M; Rametta R; Cespiati A; Pelusi S; Ferri N; Ranzani V; Nobili V; Pihlajamaki J; Fracanzani AL; Badiali S; Petta S; Fargion S; Romeo S; Kozlitina J; Valenti L
J Lipid Res; 2019 Jun; 60(6):1144-1153. PubMed ID: 30918065
[TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.
Sharma V; Forte TM; Ryan RO
Curr Opin Lipidol; 2013 Apr; 24(2):153-9. PubMed ID: 23241513
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.
Sharma V; Ryan RO; Forte TM
Biochim Biophys Acta; 2012 May; 1821(5):795-9. PubMed ID: 22209939
[TBL] [Abstract][Full Text] [Related]
11. Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).
Turpeinen H; Oksanen A; Kivinen V; Kukkurainen S; Uusimäki A; Rämet M; Parikka M; Hytönen VP; Nykter M; Pesu M
J Biol Chem; 2013 Dec; 288(51):36610-23. PubMed ID: 24178295
[TBL] [Abstract][Full Text] [Related]
12. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases.
Seidah NG; Hamelin J; Mamarbachi M; Dong W; Tardos H; Mbikay M; Chretien M; Day R
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3388-93. PubMed ID: 8622945
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-V; a potent triglyceride reducer.
Nilsson SK; Heeren J; Olivecrona G; Merkel M
Atherosclerosis; 2011 Nov; 219(1):15-21. PubMed ID: 21831376
[TBL] [Abstract][Full Text] [Related]
14. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism.
Lookene A; Beckstead JA; Nilsson S; Olivecrona G; Ryan RO
J Biol Chem; 2005 Jul; 280(27):25383-7. PubMed ID: 15878877
[TBL] [Abstract][Full Text] [Related]
16. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the structure-function properties of wild-type human apoA-V and a C-terminal truncation associated with elevated plasma triglycerides.
Stankov S; Vitali C; Park J; Nguyen D; Mayne L; Englander SW; ; Levin MG; Vujkovic M; Hand NJ; Phillips MC; Rader DJ
medRxiv; 2023 Feb; ():. PubMed ID: 36865344
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice.
Wetsel WC; Rodriguiz RM; Guillemot J; Rousselet E; Essalmani R; Kim IH; Bryant JC; Marcinkiewicz J; Desjardins R; Day R; Constam DB; Prat A; Seidah NG
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17362-7. PubMed ID: 24101515
[TBL] [Abstract][Full Text] [Related]
19. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor).
Ben Djoudi Ouadda A; Gauthier MS; Susan-Resiga D; Girard E; Essalmani R; Black M; Marcinkiewicz J; Forget D; Hamelin J; Evagelidis A; Ly K; Day R; Galarneau L; Corbin F; Coulombe B; Çaku A; Tagliabracci VS; Seidah NG
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1996-2013. PubMed ID: 31553664
[TBL] [Abstract][Full Text] [Related]
20. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
Su X; Kong Y; Peng DQ
Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
